Systems of innovation and the adoption of biotechnologies: the case of Mexico Online publication date: Sat, 07-Jun-2014
by Julieta Flores-Amador
International Journal of Biotechnology (IJBT), Vol. 13, No. 1/2/3, 2014
Abstract: Developed countries have been adopting modern biotechnologies relying on innovation systems that nurture the financial, technological and specialised human resources needed to achieve innovations, especially in human health biotechnologies (Niosi et al., 2005; Cockburn and Stern, 2010). In the last two decades, some emerging countries have attempted to adopt modern biotechnologies in their industries. However, these countries face unstructured institutional frameworks that affect their innovation systems (Niosi and Reid, 2007); still few innovations have been developed and some local firms have incorporated modern biotechnologies into their productions processes (Nature Biotechnology, 2004). Under these circumstances, a general question is raised: what are the characteristics of the firms adopting biotechnologies in emerging countries? In order to answer this question I take the case of Mexico. Two types of firms adopting biotechnologies were identified, only those that have developed absorptive capabilities have benefited from both national and international partners.
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Biotechnology (IJBT):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email subs@inderscience.com
Our Blog 
Follow us on Twitter 
Visit us on Facebook